European stroke prevention study 2: Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke

International Journal of Clinical Practice

Volumn 51, Issue 4, 1997, Pages 205-208

  Forbes, C D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; DIPYRIDAMOLE;

AGED; ARTICLE; BLEEDING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MIXTURE; DYSPEPSIA; FEMALE; FOLLOW UP; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECONDARY PREVENTION; STOMACH PAIN; STROKE; TRANSIENT ISCHEMIC ATTACK; VERTIGO; VOMITING;

EID: 0030864167     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1742-1241.1997.tb11433.x     Document Type: Article

References (5)

1. Weisenberger H, Nehmiz G, Su CAPF. Cyclo-oxygenase and collagen-induced aggregation in whole blood by acetylsalicylic acid (ASA) 10mg bd, 25mg bid and po over eight days to healthy volunteers. Personal communication, 1991.
2. Müller TH, Su CAPF, Weisenberger H et al. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo. Br J Clin Pharmacol 1990; 30: 179-186.
3. ESPS Group. The European Stroke Prevention Study (ESPS): principal endpoints. Lancet 1987; ii: 1351-1354.
4. ESPS Group. European Stroke Prevention Study. Stroke 1990; 21: 1122-1130.
5. Bertrand-Hardy JM, Cunha L, Forbes C et al. European Stroke Prevention Study 2: baseline data. J Neurol Sci 1995; 131(Suppl): 1-58.